Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

GAITHERSBURG, Md., March 22, 2013 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012.  For the year ended December 31, 2012, the Company reported a net loss of $14.1 million, or $1.09 per share, compared with a net loss of $7.4 million, or $0.58 per share, for the year ended December 31, 2011. GenVec ended the year with $15.3 million in cash, cash equivalents, and short-term investments. 

"In 2012 we continued to make progress in our hearing restoration program, partnered with Novartis, and advanced the development of our product pipeline and core technologies," stated Cynthia Collins , GenVec's President and CEO.  "Other changes implemented since my joining GenVec in May were reducing our workforce to preserve capital and discontinuing spending on non-funded programs.  We continue to seek sources of non-dilutive funding to advance our programs and to reduce expenses to preserve cash."

2012 and Recent Corporate HighlightsHearing Restoration

  • We extended our Research Collaboration and License Agreement with Novartis.  Under the extension, Novartis will fund research at GenVec through January 2014 to support its hearing loss and balance disorders program.
  • RSV Vaccine

  • GenVec conducted a successful pre-IND interaction with the U.S. Food and Drug Administration (FDA) to obtain guidance on the development plan for its vaccine against respiratory syncytial virus (RSV).  The outcome of the pre-IND interaction was obtaining clarification on the nonclinical, clinical, and chemistry, manufacturing, and control (CMC) requirements that need to be met in order to submit an acceptable IND.
     
  • GenVec received a grant of approximately $590,000 over two years from the Natio
    '/>"/>

  • SOURCE GenVec, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
    2. GenVec Appoints Cynthia Collins as President and CEO
    3. GenVec Reports Inducement Award
    4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
    5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
    6. GenVec Reports Second Quarter 2012 Financial Results
    7. GenVec Reports Third Quarter 2012 Financial Results
    8. GenVec to Present at 25th Annual ROTH Conference
    9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
    10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)...  Nonin Medical, Inc., the inventor of finger pulse ... today that Mark VanderWerf , Nonin,s Vice President ... the American Telemedicine Association,s (ATA) Industry Council and will ... ATA is the leading international resource and advocate promoting ... and its diverse membership work to transform healthcare to ...
    (Date:7/23/2014)... YORK , July 23, 2014  When it comes ... Wagner is ready to roll out the red carpet. ... welcome an influx of HAL 9000-like robots into our human ... right now, there,s a pressing need to apply new technologies ... The worldwide market for medical robotics is expected to increase ...
    (Date:7/23/2014)... July 23, 2014 Inovio Pharmaceuticals, ... results from its randomized, double-blind, placebo-controlled phase ... biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated ... 18. Treatment with VGX-3100, Inovio,s HPV16/18-specific immunotherapy, ... CIN1 or no disease, meeting the study,s ...
    Breaking Medicine Technology:Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5
    ... 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... present at the Piper Jaffray 23rd Annual Health Care Conference ... (6:00 a.m. Pacific Time) at The New York Palace in ... Officer, and Craig M. Audet, Arena,s Vice President, Global Regulatory ...
    ... YORK, Nov. 23, 2011 Reportlinker.com ... report is available in its catalogue: ... Global Medical Devices Industry 2011–2012: Market ... Forecasts, Medical Devices Industry Procurement and ...
    Cached Medicine Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference 3Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 2Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 3Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 4Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 5Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 6Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 7Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 8Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 9Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 10Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 11Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 12Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 13Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 14Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 15
    (Date:7/23/2014)... China,s Northwest Agricultural and Forestry University in Shaanxi province, ... memorandum of agreement that lays the groundwork for establishing ... China. , The signing ceremony was held in the ... officials of the U.S. Department of Agriculture and China,s ... a landmark event for UC Davis and for our ...
    (Date:7/23/2014)... 2014 Thousands of DePuy Pinnacle hip ... a federal multidistrict litigation underway in U.S. District Court, ... to an Order dated July 18th, U.S. District Judge ... of a $1,000 fee for the preservation and return ... other things, the Order noted that there is no ...
    (Date:7/23/2014)... PA (PRWEB) July 23, 2014 Four ... have been lauded in the latest ranking of the ... Report . Released online today and slated for ... Guide recognizes Allegheny General Hospital (AGH), Forbes Hospital, Saint ... medical centers across multiple clinical specialties. , ...
    (Date:7/23/2014)... Amy Norton HealthDay Reporter ... timing of a girl,s first menstrual period may be determined ... study suggests. Researchers have identified over 100 regions ... -- a woman,s first menstrual period. The researchers hope these ... of diseases ranging from type 2 diabetes to breast cancer. ...
    (Date:7/23/2014)... Ticket Down is a reputable ... at Michigan Stadium . One of the most anticipated ... held at the Big House in Ann Arbor. Michigan Stadium, ... home to a game between Manchester United from the English ... will be held on August 2nd and could be the ...
    Breaking Medicine News(10 mins):Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Gene Study Gives New Insight Into Puberty in Girls 2Health News:Gene Study Gives New Insight Into Puberty in Girls 3Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 3
    ... country of Tanzania were more likely to stop taking ... to pay for the drugs themselves. , According the ... and Duke University Medical Center researchers, HIV-infected patients who ... fare better. , Our findings suggest that efforts to ...
    ... may have solved the mystery surrounding the healing properties of ... gold salts as a treatment for rheumatoid arthritis and other ... in the early 1900s to ease the pain and swelling ... cost: The shots took months to take effect and ...
    ... TORONTO, Oct. 22 /PRNewswire/ - IntelliPharmaCeutics Ltd. ... to its generic drug,commercialization activities. In ... that the Company,s operating,affiliate IntelliPharmaCeutics Corp. ("IntelliPharmaCeutics") ... Drug Administration for the filing of,IntelliPharmaCeutics, generic ...
    ... MRSA on Contact, LAS VEGAS, Oct. ... (Website: http://www.skinvisible.com ) has formulated,a product ... of the Super-Bug, MRSA,(methicillin-resistant Staphylococcus aureus) in ... antibacterial hand sanitizer lotion made,with Invisicare(R), is ...
    ... of Federal Pre-Emption in Riegel v. Medtronic, Inc., ... the Advanced Medical Technology Association,(AdvaMed) filed a joint amicus ... of Riegel v. Medtronic, Inc. arguing that the FDA ... The brief states that,no other legislative or regulatory entity ...
    ... of Plastic Surgeons Donates Helmets to Local Public,Schools, ... of,Plastic Surgeons (ASPS) will donate 2,000 multi-sport helmets ... prevent facial injuries and,fractures. The event will be ... Thursday, October 25, from 10:00 - 11:30 a.m., ...
    Cached Medicine News:Health News:Clues to ensuring anti-HIV drugs are taken in Africa 2Health News:Clues to ensuring anti-HIV drugs are taken in Africa 3Health News:Scientists discover how gold eases pain of arthritis 2Health News:IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities 2Health News:Future MRSA Outbreaks in Schools are Preventable! 2Health News:Future MRSA Outbreaks in Schools are Preventable! 3Health News:Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc. 2Health News:Children of Baltimore Get Free 'Helmets 4 Safety' 2Health News:Children of Baltimore Get Free 'Helmets 4 Safety' 3
    Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
    The uncemented hip joint prosthesis system....
    The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
    The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
    Medicine Products: